- Home
- ZYME vs HUYA Comparison
ZYME vs HUYA Comparison
Compare ZYME & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- HUYA
- Stock Information
- Founded
- ZYME 2003
- HUYA 2014
- Country
- ZYME United States
- HUYA China
- Employees
- ZYME N/A
- HUYA N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- HUYA Computer Software: Programming Data Processing
- Sector
- ZYME Health Care
- HUYA Technology
- Exchange
- ZYME Nasdaq
- HUYA Nasdaq
- Market Cap
- ZYME 846.1M
- HUYA 754.5M
- IPO Year
- ZYME 2017
- HUYA 2018
- Fundamental
- Price
- ZYME $11.43
- HUYA $3.77
- Analyst Decision
- ZYME Buy
- HUYA Buy
- Analyst Count
- ZYME 7
- HUYA 3
- Target Price
- ZYME $19.50
- HUYA $4.57
- AVG Volume (30 Days)
- ZYME 449.0K
- HUYA 923.7K
- Earning Date
- ZYME 05-08-2025
- HUYA 05-13-2025
- Dividend Yield
- ZYME N/A
- HUYA 67.28%
- EPS Growth
- ZYME N/A
- HUYA N/A
- EPS
- ZYME N/A
- HUYA N/A
- Revenue
- ZYME $93,384,000.00
- HUYA $838,372,907.00
- Revenue This Year
- ZYME $34.23
- HUYA $5.41
- Revenue Next Year
- ZYME $68.78
- HUYA $3.09
- P/E Ratio
- ZYME N/A
- HUYA N/A
- Revenue Growth
- ZYME 85.05
- HUYA N/A
- 52 Week Low
- ZYME $8.21
- HUYA $2.82
- 52 Week High
- ZYME $17.70
- HUYA $6.43
- Technical
- Relative Strength Index (RSI)
- ZYME 45.92
- HUYA 57.79
- Support Level
- ZYME $11.46
- HUYA $3.55
- Resistance Level
- ZYME $11.81
- HUYA $3.90
- Average True Range (ATR)
- ZYME 0.59
- HUYA 0.12
- MACD
- ZYME -0.05
- HUYA 0.00
- Stochastic Oscillator
- ZYME 27.62
- HUYA 62.86
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About HUYA HUYA Inc. American depositary shares each representing one ordinary share
Established in 2011, Huya is the largest online game livestreaming company in China. Headquartered in Guangzhou, Huya mainly provides livestreamed videos on esports games such as League of Legends and Honor of Kings and collects virtual tips from viewers. Its products include the Huya Live platform in China and Nimo TV in Southeast Asia and South America. As of 2023, Huya was a subsidiary of Tencent, which owned 63% of its equity stake and held 94% of the voting power.